Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer

Mirko Marabese, Sergio Marchini, Eleonora Marrazzo, Pietro Mariani, Dario Cattaneo, Roldano Fossati, Anna Compagnoni, Mauro Signorelli, Ute M. Moll, A. Maria Codegoni, Massimo Broggini

Research output: Contribution to journalArticlepeer-review


The p53 gene has been investigated for its role in epithelial ovarian cancer but data collected until now are contradictory. The evidence that p53 belongs with p63 and p73 to a family of transcription factors re-opened interest in this gene family. Here, we used quantitative real time RT-PCR to determine expression levels of TAp53, TAp73 and their N-terminal splice variants in a cohort of 169 ovarian cancer patients with stage I and stage III disease. The TAp73 levels in stage III biopsies differed by 100-fold depending on the p53 status and overall survival appears to be significantly related to ΔNp73 expression. Kaplan-Meyer analyses did not suggest a correlation between overall survival and levels of TAp73, ΔNp73 or the ΔNp73/TAp73 ratio. In conclusion, these data suggest that at least in our patient cohort p53 and p73 expression levels are not correlated to malignant progression of ovarian cancer. They might, however, play a role in tumour initiation.

Original languageEnglish
Pages (from-to)131-141
Number of pages11
JournalEuropean Journal of Cancer
Issue number1
Publication statusPublished - Jan 2008


  • Ovarian cancer
  • p53
  • p73
  • Splice variants

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology


Dive into the research topics of 'Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer'. Together they form a unique fingerprint.

Cite this